Invention Grant
- Patent Title: Naltrexone long acting formulations and methods of use
- Patent Title (中): 纳曲酮长效制剂及使用方法
-
Application No.: US11083167Application Date: 2005-03-17
-
Publication No.: US07919499B2Publication Date: 2011-04-05
- Inventor: Elliot Ehrich
- Applicant: Elliot Ehrich
- Applicant Address: US MA Waltham
- Assignee: Alkermes, Inc.
- Current Assignee: Alkermes, Inc.
- Current Assignee Address: US MA Waltham
- Agency: Elmore Patent Law Group, P.C.
- Agent Carolyn S. Elmore; Darlene A. Vanstone
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K31/56 ; A01N43/42 ; A01N45/00 ; A61F13/00
Abstract:
The inventions described herein arose from unexpected discoveries made during clinical trials with a long acting formulation of naltrexone. As such, the invention includes a method for treating an individual in need of naltrexone comprising the step of parenterally administering a long acting formulation comprising naltrexone and to the use of naltrexone in the manufacture of medicaments for use in such methods.
Public/Granted literature
- US20050245558A1 Naltrexone long acting formulations and methods of use Public/Granted day:2005-11-03
Information query
